ArticleMolecular oncology2018
Intratumor heterogeneity defines treatment-resistant HER2+ breast tumors.
Inga H Rye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
71 papers cite itlatest 60 shown
this papertrialcites it
ArticleMolecular oncology2018
Inga H Rye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.